MedPath

University of North Carolina - Chapel Hill Endowment Fund

🇺🇸United States
Ownership
Private, Subsidiary
Employees
-
Market Cap
-
Website

Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens

Phase 2
Withdrawn
Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions
Drug: Standard of care
Drug: Retinoic acid
First Posted Date
2011-01-12
Last Posted Date
2017-02-23
Lead Sponsor
University of North Carolina, Chapel Hill
Registration Number
NCT01275274
Locations
🇺🇸

UNC Kidney Center, Chapel Hill, North Carolina, United States

Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab

Phase 2
Withdrawn
Conditions
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Interventions
Drug: Standard of care treatment
Drug: eculizumab
First Posted Date
2011-01-12
Last Posted Date
2017-02-23
Lead Sponsor
University of North Carolina, Chapel Hill
Registration Number
NCT01275287
Locations
🇺🇸

UNC Kidney Center, Chapel Hill, North Carolina, United States

Peanut Oral Immunotherapy (OIT) - Initial Pilot Study in Adults

Phase 1
Terminated
Conditions
Peanut Allergy
Interventions
First Posted Date
2011-01-11
Last Posted Date
2018-03-27
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
5
Registration Number
NCT01274429
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Second-Generation Antipsychotic Treatment Indication Effectiveness And Tolerability In Youth (Satiety) Study

Completed
Conditions
Schizophrenia
Schizophreniform Disorder
Mood Disorder
Schizoaffective Disorder
Bipolar Disorder
Depressive Disorder, Not Otherwise Specified
Prodromal Schizophrenia
Major Depressive Disorder
Mood Disorder, Not Otherwise Specified
Psychotic Disorder, Not Otherwise Specified
First Posted Date
2011-01-04
Last Posted Date
2013-02-22
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
4
Registration Number
NCT01269710
Locations
🇺🇸

University of North Carolina, Chapel Hill, North Carolina, United States

Effects of Sulforaphane (SFN) on Immune Response to Live Attenuated Influenza Virus in Smokers and Nonsmokers

Not Applicable
Completed
Conditions
Smoking
Interventions
Dietary Supplement: Broccoli sprout homogenate
Dietary Supplement: Alfalfa sprout homogenate
First Posted Date
2011-01-04
Last Posted Date
2014-01-29
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
51
Registration Number
NCT01269723
Locations
🇺🇸

UNC Center for Environmental Medicine, Asthma and Lung Biology, Chapel Hill, North Carolina, United States

Bioavailability Study Comparing Tolvaptan Administered Via Nasogastric Tube to Tolvaptan Tablets Swallowed Intact

Phase 1
Completed
Conditions
Healthy
Interventions
First Posted Date
2010-12-16
Last Posted Date
2012-12-07
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
29
Registration Number
NCT01261481
Locations
🇺🇸

University of North Carolina Healthcare, Chapel Hill, North Carolina, United States

A Representational Intervention to Promote Preparation for End-of-life Decision Making

Not Applicable
Completed
Conditions
End Stage Renal Disease
Interventions
Behavioral: the SPIRIT intervention
First Posted Date
2010-12-13
Last Posted Date
2017-09-25
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
210
Registration Number
NCT01259011
Locations
🇺🇸

University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, United States

Acceptability of a Cereal for Complementary Feeding of Infants and Young Children Made From Caterpillars

Not Applicable
Completed
Conditions
Malnutrition
Stunting of Growth
Interventions
Dietary Supplement: caterpillar cereal
First Posted Date
2010-12-13
Last Posted Date
2011-08-30
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
40
Registration Number
NCT01258647
Locations
🇨🇬

Kinshasa School of Public Health, Kinshasa, Congo

The Effect of Pregnancy on the PK of Isentress®: A Longitudinal Investigation in the Second and Third Trimesters

Withdrawn
Conditions
HIV
Pregnancy
Interventions
Other: Pharmacokinetics
First Posted Date
2010-12-02
Last Posted Date
2024-02-28
Lead Sponsor
University of North Carolina, Chapel Hill
Registration Number
NCT01251601

Endothelial Cell Loss and Induced Astigmatism After Wound-directed and Wound-assisted IOL Injection

Not Applicable
Completed
Conditions
Cataracts
Cataract Surgery
Interventions
Procedure: Lens insertion during cataract surgery
First Posted Date
2010-12-01
Last Posted Date
2010-12-01
Lead Sponsor
University of North Carolina, Chapel Hill
Target Recruit Count
72
Registration Number
NCT01250964
Locations
🇺🇸

Kittner Eye Center, Chapel Hill, North Carolina, United States

© Copyright 2025. All Rights Reserved by MedPath